Target intelligence / Profile preview

Blood glucose stabilization via slow carbohydrate absorption

Molecular classification
Other
01

Overview

The concept of **blood glucose stabilization via slow carbohydrate absorption** describes dietary or pharmacological interventions that reduce the rate at which ingested carbohydrates are digested into glucose and absorbed into the bloodstream[2][3]. This can be achieved through foods rich in fiber and slowly digestible starch (SDS), enzyme inhibitors like acarbose that block carbohydrate-digesting enzymes in the gut, or foods with a low glycemic index. Such interventions aim to blunt the postprandial blood glucose spike and reduce demand for insulin, thus lowering the risk or aiding control of metabolic diseases like type 2 diabetes and obesity. There is no single molecule, receptor, or protein target—rather, the strategy exploits physiological processes involving many enzymes, transporters, and hormones[2][5][3].

Other names
Slow-release carbohydrateSlowly digestible starchGlycemic control via carbohydrate absorptionLow glycemic index approach
02

Mechanism of action

Inhibition of carbohydrate-digesting enzymes (e.g., alpha-glucosidase inhibition) - Delayed gastric emptying - Physical slow-release effects from food matrix (fiber, resistant starch)

03

Biological functions

Regulation of blood glucose levelsPostprandial glycemic controlModulation of insulin secretion
04

Disease associations

Type 2 diabetesPrediabetesMetabolic syndromeObesity
05

Safety considerations

Gastrointestinal disturbances with enzyme inhibitors (flatulence, diarrhea)[3]Risk of hypoglycemia when combined with other glucose-lowering drugs
06

Interacting drugs

Acarbose (an alpha-glucosidase inhibitor)[3]

3 more in the full profile.

07

Biomarkers

Postprandial blood glucose levelsGlycated hemoglobin (HbA1c)Glycemic index/load of foods

Beyond the preview

Go deeper on Blood glucose stabilization via slow carbohydrate absorption.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood glucose stabilization via slow carbohydrate absorption.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call